Oral tablets for black fungus develops by IIT Hyderabad, India.

Hyderabad 31 May. Researchers at the Indian Institute of Technology, Hyderabad (IIT-H), have approved the mass production of an oral solution to combat Black Fungus.
Researchers at the Indian Institute of Technology, Hyderabad (IIT-H), have approved the mass production of an oral solution to treat black fungus, providing huge relief to patients. After two years of study, the researchers are now confident that the technology can be transferred to suitable pharma partners for large-scale production. The oral solution will ensure easy medicare for patients and also affordable with a 60 mg tablet likely to cost ₹200 only. At present, Kala Azar (visceral leishmaniasis) treatment is being used for black fungus and other fungus in the country but its availability, affordability and the procedures involved make it imperative to allow emergency and immediate trial of this oral drug, feels the team of Prof. Saptarshi Majumdar and Dr. Chandra Shekhar Sharma and their Ph.D scholars Mrunalini Gaydhane and Anindita Laha, who have been working on the oral solution for the last two years. According to IIT-H, Prof. Saptarshi Majumdar and Dr. Chandra Shekhar Sharma from the Department of Chemical Engineering made a proven study in 2019 about oral nanofibrous Amphotericin B (AmB) to be effective for Kala Azar.